Receptors of calciotropic hormones

Hormone and Metabolic Research

Volumn 29, Issue 3, 1997, Pages 128-134

  Findlay, D M ^a   Martin, T J ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

calcitonin; isoforms; osteoblasts; osteocla sts; PTH PTHrP; receptor; regulation

Indexed keywords

CALCITONIN; CALCITONIN RECEPTOR; HORMONE RECEPTOR; MESSENGER RNA; PARATHYROID HORMONE RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SENSITIVITY; MOLECULAR CLONING; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPECIES DIFFERENCE;

EID: 0030906444     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979005     Document Type: Conference Paper

References (77)

1. Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation. Endocrine Reviews 13: 66-80 (1992).
2. Martin TJ, Allan EH, Fukumoto S, Moseley JM: Some aspects of the anabolic action of parathyroid hormone. Miner Electrolyte Metab 21: 87-90 (1995).
3. Yamamoto M, Seedor JG, Rodan GA, Balena R: Endogenous calcitonin attenuates parathyroid hormone-induced cancellous bone loss in the rat. Endocrinology 136: 788-795 (1995).
4. Juppner H, Abou-Samra A-B, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski Jr LF, Hock J, Potts Jr JT, Kronenberg HM, Segre GV: A receptor for parathyroid hormone (PTH) and PTH-related peptide is a novel G protein-linked receptor. Science 254: 1024-1024 (1991).
5. Abou-Samra A-B, Juppner H, Force T, Freeman MW, Kong X-F, Schipani E, Urena P, Richards J, Bonventre JV, Potts Jr JT, Kronenberg HM, Segre GV: Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increase intracellular free calcium. Proc Natl Acad Sci 89: 2732-2736 (1992).
6. Schipani E, Karga H, Karapalis AC, Potts Jr JT, Kronenberg HM, Segre GV, Abou-Samra A-B, Juppner H: Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology 132: 2157-2165 (1993).
7. Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall REH, Stapleton D, Diefenbach-Jagger H, Ure F, Michelangeli VP, Simmons HA, Raisz LG, Martin TJ: Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science 238: 1568-1570 (1987).
8. Juppner H, Abou-Samra A-B, Urena S, Cu W, Potts Jr JT, Segre GV: The parathyroid hormone-like poeptide associated with humoral hypercalcemia of malignancy and parathyroid hormone bind to the same receptor on the plasma membrane of ROS 17/2.8 cells. J. Biol Chem 263: 8557-8564 (1988).
9. Orloff JJ, Wu TL, Stewart AF: Parathyroid hormone-like proteins: biochemical responses and receptor interactions. Endocrine Rev 10: 476-495 (1989).
10. Sprengel R, Eva C: Hormone receptors, in: Handbook of Receptors and Channels. Peroutka SJ (ed), CRC Press, Florida (1994), 153-157.
11. Urena P, Kong X-F, Abou-Samra A-B, Juppner H, Kronenberg HM, Potts Jr JT, Segre GV: Parathyroid hormone (PTH)/PTH related peptide (PTHrP) receptor mRNA are widely distributed in rat tissues. Endocrinology 133: 617-623 (1993).
12. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLS, Kronenberg HM, Muligan RC: Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone related peptide gene. Genes and Develop 8: 277-289 (1994).
13. Amizuka N, Warshaursky H, Henderson SE, Goltzman D, Karaplis AC: Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol 126: 1611-1623 (1994).
14. Weir E, Philbrick W, Neff L, Amling M, Baron R, Broadus A: Targetted overexpression of parathyroid hormone-related peptide in chrondrocytes causes skeletal dysplasia and delayed osteogenesis. J Bone Min Res 10: S157 (1995).
15. Schipani E, Kruse K, Juppner H: A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268: 98-100 (1995).
16. Pines M, Adams AE, Adams S, Stuekle R, Bessalle V, Rashti-Behar M, Chorev M, Rosenblatt M, Suva LJ: Generation and characterization of human kidney cell lines stably expressing recombinant human PTH/PTHrP receptor: lack of interaction with a C-terminal human PTH peptide. Endocrinology 135: 1713-1716 (1994).
17. Lee C, Gardella TJ, Abou-Samra A-B, Nussbaum SR, Segre GV, Potts Jr JT, Kronenberg HM, Juppner H: Role of the extracellular regions of the PTH/PTHrP receptor in hormone binding. Endocrinology 135: 1488-1495 (1994).
18. 2]PTH-(1-34) binding and signalling in the transmembrane region of the parathyroid hormone receptor gene. Endocrinology 135: 1186-1194 (1994).
19. Iidaklein A, Guo J, Xie LY, Juppner H, Potts JT, Kronenberg HM, Bringhurst FR, Abousamra AB, Segre GV: Truncation of the carboxy-terminal region of the rat parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenyl cyclase but not phospholipase C. J Biol Chem 270: 8458-8465 (1995).
20. Kong X-F, Schipani E, Lanske B, Joun H, Karperien M, Defize LHK, Juppner H, Potts Jr JT, Segre GV, Kronenberg HM, Abou-Samra AB: The rat, mouse and human genes encoding parathyroid hormone-related peptide are highly homologous. Biochem Biophys Res Comm 200: 1290-1299 (1994).
21. Usdin TB, Gruber C, Bonner TI: Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. Endocrinology 270: 15455-15458 (1995).
22. Rodda CP, Kubota M, Heath JA, Ebeling PR, Moseley JM, Care AD, Caple IW, Martin TJ: Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: comparison with a similar protein implicated in humoral hypercalcemia of malignancy. J Endocrinol 117: 261-271 (1988).
23. Bringhurst FR, Juppner H, Guo J, Urena P, Potts Jr JT, Kronenberg HM, Abou-Samra A-B, Segre GV: Cloned, stably expressed parathyroid hormone (PTH)/PTHrP-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells. Endocrinology 132: 2090-2098 (1993).
24. Schneider HG, Michelangeli VP, Frampton RJ, Grogan JL, Ikeda K, Martin TJ, Findlay DM: Transforming growth factor-β modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells. Endocrinology 131: 1383-1389 (1992).
25. Jongen JWM, Willemstein-Van Hove EC, Van Der Meer JM, Bos MP, Juppner H, Segre GV, Abou-Samra A-B, Feyen JHM, Herrmann-Erlee MPM: Down regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by transforming growth factor-β in primary fetal rat osteoblasts. Endocrinology 136: 3260-3266 (1995).
26. McCauley LK, Beecher CA, Melton ME, Werkmeister JR, Juppner H, Abou-Samra A-B, Segre GV, Rosol TJ: Transforming growth factor-β1 regulates steady state PTH/PTHrP receptor mRNA levels and PTHrP binding in ROS17/2.8 cells. Mol Cell Endocrinol 101: 331-336 (1994).
27. Schneider H-G, Allan EH, Moseley JM, Martin TJ, Findlay DM: Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumour necrosis factor α and retinoic acid in UMR106-06 osteoblast-like osteosarcoma cells. Biochem. J 280: 451-457 (1991).
28. Yamamoto I, Potts JT, Segre GV: Glucocorticoids increase parathyroid hormone receptors in rat osteoblastic osteosarcoma cells (ROS17/2). J Bone Min Res 3: 707-712 (1988).
29. Ikeda K, Michelangeli VP, Martin TJ, Findlay DM: Type I collagen substrate increases calcitonin and parathyroid hormone receptor-mediated signal transduction in UMR 106-06 osteoblast-like cells. J Cell Physiol 156: 130-137 (1993).
30. Blind E, Bambino T, Nissenson RA: Agonist-stimulation phosphorylation of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136: 4271-4277 (1995).
31. Fukayama S, Schipani E, Juppner H, Lanske B, Kronenberg HM, Abou-Samra A-B, Bringhurst FR: Role of protein kinase-A in homologous down-regulation of parathyroid hormone (PTH)/PTHrP-related peptide receptor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells. Endocrinology 134: 1851-1858 (1994).
32. Okano S, Wu TL, Huang X, Pirola CJ, Juppner H, Abou-Samra A-B, Segre GV, Iwasaki K, Fagin JA, Clemens TL: Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor and its messenger ribonucleic acid in rat aortic vascular smooth muscle cells and UMR osteoblast-like cells: cell-specific regulation by angiotensin-II and PTHrP. Endocrinology 135: 1093-1099 (1994).
33. Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LF, Lodish H, Goldring SR: Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254: 1022-1024 (1991).
34. Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, Manning CA, Lodish HF, Krane SM, Goldring SR: Cloning characterization and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest 90: 1726-1735 (1992).
35. Sexton PM, Houssami S, Hilton JM, O'Keeffe LM, Center RJ, Gillespie MT, Darcy PJ, Findlay DM: Identification of brain isoforms of rat calcitonin receptor. Mol Endocrinol 7: 815-821 (1993).
36. Albrant KE, Mull, Brady EMG, Herich J, Moore CX, Beaumont K: Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin. FEBS Lett 325: 225-230 (1993).
37. Yamin M, Gorn AH, Flannery MR, Jenkins NA, Gilbert DJ, Copeland NG, Tapp DR, Krane SM, Goldring SR: Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene. Endocrinology 135: 2635-2643 (1994).
38. Shyu J-F, Baron R, Horne WC: Rabbit osteoclasts express two isoforms of the calcitonin receptor, one of which is novel. J Bone Min Res 10: S486 (1995).
39. Kuestner RE, Elrod RD, Grant FJ, Hagen FS, Kuijper JL, Matthewes SL, O'Hara PJ, Sheppard PO, Stroop SD, Thompson DL, Whitmore TE, Findlay DM, Houssami S, Sexton PM, Moore EE: Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol Pharmacol 46: 246-255 (1994).
40. 2+/inositol phosphate signalling pathways. Mol Endocrinol 6: 551-556 (1992).
41. Force T, Bonventre JV, Flannery MR, Gorn AH, Yamin M, Goldring SR: A cloned porcine renal calcitonin receptor couples to adenylyl cyclase and phospholipase C. Am J Physiol 262: F1110-F1115 (1992).
42. Houssami S, Findlay DM, Brady CL, Myers DE, Martin TJ, Sexton PM: Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinology 135: 183-190 (1994).
43. Stroop SD, Thompson DL, Kuestner RE, Moore EE: A recombinant human calcitonin receptor functions as an extracellular calcium receptor. J Biol Chem 268: 19927-19930 (1993).
44. Findlay DM, Houssami S, Sexton PM, Brady CL, Martin TJ, Myers DE: Calcium inflow in cells transfected with cloned rat and porcine receptors. Biochem Biophys Acta 1265: 213-219 (1995).
45. Malgaroli A, Meldolesi J, Zambonin Zallone A, Teti A: Control of cytosolic free calcium in rat and chicken osteoclasts: the role of extracellular calcium and calcitonin. J Biol Chem 264: 14342-14347 (1989).
46. 2+ sensing is modulated by pH in human osteoclast-like cells in vitro. Am J Physiol 36: C961-C968 (1994).
47. Sexton PM, McKenzie JS, Mendelsohn FAO: Evidence for a new class of clalcitonin/calcitonin gene-related peptide binding site in brain. Neurochem Int 12: 323-335 (1988).
48. Houssami S, Findlay DM, Brady CL, Martin TJ, Epand RM, Moore EE, Murayama E, Tamura T, Orlowski RC, Sexton PM: Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation. Mol Pharmacol 47: 798-809 (1995).
49. Nakamuta H, Orlowski RC, Epand RM: Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs. Endocrinology 127: 163-169 (1990).
50. Ikegame M, Rakopoulos M, Zhou H, Houssami S, Moseley JM, Martin TJ, Findlay DM: Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Miner Res 10: 59-65 (1994).
51. Sexton PM: Central nervous binding sites for calcitonin and calcitonin gene-related peptide. Mol Neurobiol 5: 251-276 (1991).
52. Zolneirowicz S, Cron P, Solinas-Tolda S, Fries R, Lin HY, Hemmings BA: Isolation, characterization and chromosomal localization of the porcine calcitonin receptor gene. J Biol Chem 269: 19530-19538 (1994).
53. Nussenveig DR, Mathew S, Gershengorn MC: Alternative splicing of a 48-nucleotide exon generates two isoforms of the human calcitonin receptor. Endocrinology 136: 2047-2051 (1995).
54. Egerton M, Needham M, Evans S, Millest A, Cerillo G, McPheat J, Popplewell M, Johnstone D, Hollis M: Identification of multiple human calcitonin receptor isoforms; heterologous expression and pharmacological characterization. J Mol Endocrinol 14: 179-189 (1995).
55. Gorn AH, Rudolph SM, Flannery MR, Morton CC, Weremowicz S, Wang J-T, Krane SM, Goldring SR: Expression of two skeletal calcitonin receptor isoforms cloned from a giant tumor of bone. The first intracellular domain modulates ligand binding and signal transduction. J Clin Invest 95: 2680-2691 (1995).
56. Stroop SD, Kuestner RE, Serwold TF, Chen L, Moore EE: Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. Biochem 34: 1050-1057 (1995).
57. Bergwitz CT, Gardella J, Flannery MR, Goldring SR, Juppner H: Hybrids between the receptors for parathyroid hormone (PTH)/PTH-related peptide (PTHrP) and calcitonin (CT) are activated by corresponding hybrid ligands: evidence for a common functional architecture of ligand-receptor interaction. J Bone Min Res 10: S141 (1995).
58. Kurokawa M, Michelangeli VP, Findlay DM: Induction of calcitonin receptor expression by glucocorticoids in T47D human breast cancer cells. J Endocrinol 130: 321-326 (1991).
59. Wada S, Akatsu T, Tamura T, Takahashi N, Suda T, Nagata N: Glucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells. J Bone Min Res 9: 1705-1712 (1994).
60. Findlay DM, Michelangeli VP, Robinson PJ: Protein kinase-C-induced down regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells. Endocrinology 125: 2656-2663 (1989).
61. Findlay DM, deLuise M, Michelangeli VP, Martin TJ: Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line. J Endocrinol 88: 271-281 (1981).
62. Findlay DM, Martin TJ: Relationship between internalization and calcitonin-induced receptor loss in T47D cells. Endocrinology 115: 78-83 (1984).
63. Findlay DM, Martin TJ: Kinetics of calcitonin receptor internalization in lung cancer (BEN) and osteogenic sarcoma (UMR 106-06) cells. J Bone Min Res 1: 277-283 (1986).
64. Schneider H-G, Raue F, Bollenbach N, Scherübl H, Zeigler R: Internalization of calcitonin receptors in primary rat kidney cell cultures. Acta Endocrinol (Copenh) 122: 255-262 (1990).
65. Findlay DM, Ng KW, Niall M, Martin TJ: Processing of calcitonin and epidermal growth factor after binding to receptors in human breast cancer cells (T47D). Biochem J 206: 343-350 (1982).
66. Findlay DM, Houssami S, Lin HY, Myers DE, Brady CL, Darcy PK, Ikeda K, Martin TJ, Sexton PM: Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity. Mol Endocrinol 8: 1691-1700 (1994).
67. Nygaard SC, Kuestner RE, Moore EE, Stroop SD: Phosphorylation of the calcitonin receptor localized at the C-terminus. J Bone Min Res 10: S141 (1995).
68. Lamp SJ, Findlay DM, Moseley JM, Martin TJ: Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T47D). J Biol Chem 256: 12269-12274 (1981).
69. Michelangeli VP, Findlay DM, Moseley JM, Martin TJ: Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells. J Cyclic Nucleotide Prot Phos Res 9: 129-142 (1983).
70. Wada S, Martin TJ, Findlay DM: Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Endocrinology 136: 2611-2621 (1995).
71. Takahashi S, Goldring S, Katz M, Hilsenbeck S, Williams R, Roodman GD: Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 95: 167-171 (1995).
72. Lee SK, Goldring SR, Lorenzo JA: Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 136: 4572-4581 (1995).
73. Tashjian Jr AH, Wright DR, Ivey JL, Pont A: Calcitonin binding sites in bone: relationship to biological response and "escape". Recent Prog Horm Res 34: 285-334 (1978).
74. Rakopoulos M, Ikegame M, Findlay DM, Martin TJ, Moseley JM: Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA. Bone 17: 447-453 (1995).
75. Ikegame M, Rakopoulos M, Mrtin TJ, Moseley JM, Findlay DM: Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor in mouse bone marrow cultures. J Bone Min Res 11: 456-465 (1996).
76. Wada S, Udagawa N, Nagata N, Martin TJ, Findlay DM: Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. Endocrinology 137: 1042-1048 (1996).
77. Wada S, Udagawa N, Martin TJ, Findlay DM: Physiological levels of calcitonin regulate the mouse osteoclast receptor by a protein kinase A-mediated mechanism. J Bone Min Res 10: S141 (1995).